| Compounds | Topics | Title | Date |
|---|---|---|---|
| HU-331 | cancer in vitro,mice | HU-331, a novel cannabinoid-based anticancer topoisomerase II inhibitor. | Jan 2007 |
| A new anticancer quinone (HU-331) was synthesized from cannabidiol. It shows significant high efficacy against human cancer cell lines in vitro and against in vivo tumor grafts in nude mice. | |||
| HU-331 | cancer in mice via experiment | A cannabinoid anticancer quinone, HU-331, is more potent and less cardiotoxic than doxorubicin: a comparative in vivo study. | Aug 2007 |
| In vivo, HU-331 was more active and less toxic than doxorubicin and thus it has a high potential for development as a new anticancer drug. | |||